EcoDrugPlus

Proteinase-Activated Receptor 1-Like

Ensembl ID : ENSOTSG00005011592
Gene Symbol: LOC112262777
3 Cross references
216 Possible Orthologues:

Purinergic Receptor P2x, Ligand-Gated Ion Channel, 3b

Ensembl ID : ENSOTSG00005006755
Gene Symbol: P2RX3B
1 Cross references
190 Possible Orthologues:

Purinergic Receptor P2x, Ligand-Gated Ion Channel, 3b

Ensembl ID : ENSOTSG00005016250
Gene Symbol: P2RX3B
1 Cross references
191 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSOTSG00005022528
Gene Symbol: P2RY1
1 Cross references
185 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSOTSG00005040056
Gene Symbol: P2RY1
1 Cross references
184 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSOTSG00005013278
Gene Symbol: P2RY12
1 Cross references
174 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSOTSG00005017673
Gene Symbol: P2RY12
1 Cross references
174 Possible Orthologues:

Purinergic Receptor P2y2

Ensembl ID : ENSOTSG00005005451
Gene Symbol: P2RY2
1 Cross references
191 Possible Orthologues:

Purinergic Receptor P2y2

Ensembl ID : ENSOTSG00005013307
Gene Symbol: P2RY2
1 Cross references
191 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSOTSG00005020494
Gene Symbol: P2RY4
1 Cross references
159 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSOTSG00005000696
Gene Symbol: P2RY4
3 Cross references
160 Possible Orthologues:

Pyrimidinergic Receptor P2y6

Ensembl ID : ENSOTSG00005005435
Gene Symbol: P2RY6
3 Cross references
176 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).